Sector valuations Guard Therapeutics International AB
Equities
GUARD
SE0021181559
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.40 SEK | -1.39% | -1.39% | -20.67% |
08-29 | First Patient Dosed in Guard Therapeutics' Phase 2B Study POINTER | CI |
08-27 | Guard Therapeutics Plans New SEK80 Million Rights Issue to Fund Kidney Drug Study | MT |
P/E ratio | Price to Book | PEG | EV / Sales | EV / EBITDA | EV / EBIT | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
-4.92x | 4.017 | 0.1x | - | -2.63x | -2.63x | - | 33.82M | ||
46.75x | 4.013 | 1.6x | 6.21x | 21.87x | 33.62x | +0.86% | 46.02B | ||
31.55x | 6.333 | 5.55x | 3.62x | 15.07x | 17.81x | -.--% | 44.31B | ||
-101.86x | 118.66 | 3.27x | 13.66x | -233.58x | -171.73x | -.--% | 31.68B | ||
74.43x | 2.344 | -2.36x | 11.32x | 40.44x | 64.15x | +0.26% | 29.63B | ||
-7.94x | 2.666 | 0.31x | 6.51x | -6.14x | -5.44x | -.--% | 28.02B | ||
32.72x | 2.493 | 1.31x | 3.22x | 14.89x | 16.02x | -.--% | 25.05B | ||
13.96x | 2.068 | 0.56x | 4.61x | 8.99x | 9.29x | -.--% | 15.38B | ||
59.5x | 4.860 | 4.13x | 9.24x | 26.35x | 29.2x | +0.45% | 11.34B | ||
28.97x | 10.91 | 0.95x | 4.52x | 21.68x | 23.3x | -.--% | 10.39B | ||
49.19x | 2.665 | -1.26x | 5.16x | 13.9x | 18.1x | -.--% | 9.89B | ||
29.87x | 2.447 | -0.94x | 2.94x | 11.78x | 14.8x | -.--% | 9.7B | ||
-12.06x | 4.529 | 1.19x | 3503.98x | -8.88x | -8.75x | -.--% | 6.99B | ||
-12.73x | 10,608.60 | -0.29x | 10.02x | -12.27x | -11.68x | -.--% | 6.86B | ||
48.57x | 4.094 | 15.42x | 8.93x | 31.14x | 44.35x | +1.15% | 6.7B | ||
24.48x | 1.886 | -1.64x | 4.37x | 18.02x | 18.73x | +0.76% | 5.51B | ||
-69.38x | 73.87 | 0.82x | 9.48x | -20.71x | -20.67x | -.--% | 5.47B | ||
-13.86x | 11.46 | -0.45x | - | -11.45x | -11.66x | -.--% | 4.98B | ||
Average | 12.07x | 603.77 | 1.57x | 225.49x | -3.97x | 3.16x | +0.20% | 16.55B | |
Weighted average by Cap. | 16.55x | 261.6 | 1.82x | 90.37x | -11.49x | 0.57x | +0.22% |
- Stock Market
- Equities
- GUARD Stock
- Sector Guard Therapeutics International AB
- Sector valuations
MarketScreener is also available in this country: United States.
Switch edition